Publicacions en col·laboració amb investigadors/es de University of Liverpool (19)

2024

  1. Acute and two-week effects of neotame, stevia rebaudioside M and sucrose-sweetened biscuits on postprandial appetite and endocrine response in adults with overweight/obesity—a randomised crossover trial from the SWEET consortium

    eBioMedicine, Vol. 102

2023

  1. Consensus Clinical Guidance for Diagnosis and Management of Adult COVID-19 Encephalopathy Patients

    Journal of Neuropsychiatry and Clinical Neurosciences, Vol. 35, Núm. 1, pp. 12-27

  2. Corrigendum to “Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study” [Journal of the Neurological Sciences. 2023 Jun 15;449:120646] (Journal of the Neurological Sciences (2023) 449, (S0022510X23001065), (10.1016/j.jns.2023.120646))

    Journal of the Neurological Sciences

  3. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition

    Journal of the Neurological Sciences, Vol. 454

  4. Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study

    Journal of the Neurological Sciences, Vol. 449

  5. Impact of acute consumption of beverages containing plant-based or alternative sweetener blends on postprandial appetite, food intake, metabolism, and gastro-intestinal symptoms: Results of the SWEET beverages trial

    Appetite, Vol. 184

2022

  1. Acute and repeated impact of sweeteners and sweetness enhancers in solid and semi-solid foods on appetite: protocol for a multicentre, cross-over, RCT in people with overweight/obesity - the SWEET Project

    BMJ open, Vol. 12, Núm. 12, pp. e063903

  2. Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System

    Annals of Neurology, Vol. 91, Núm. 6, pp. 756-771

  3. Protocol for a multicentre, parallel, randomised, controlled trial on the effect of sweeteners and sweetness enhancers on health, obesity and safety in overweight adults and children: the SWEET project

    BMJ open, Vol. 12, Núm. 10, pp. e061075

  4. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  5. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

  6. The global brain health clinical exchange platform: Translating concepts to collaborations

    Journal of the Neurological Sciences

  7. Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports

    Cephalalgia, Vol. 42, Núm. 11-12, pp. 1207-1217

2021

  1. A rational review on the effects of sweeteners and sweetness enhancers on appetite, food reward and metabolic/adiposity outcomes in adults

    Food and Function, Vol. 12, Núm. 2, pp. 442-465

  2. Approaches to Understanding COVID-19 and its Neurological Associations

    Annals of Neurology, Vol. 89, Núm. 6, pp. 1059-1067

  3. Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions

    Journal of the Neurological Sciences, Vol. 427

  4. Oxygen in Metabolic Dysfunction and Its Therapeutic Relevance

    Antioxidants and Redox Signaling, Vol. 35, Núm. 8, pp. 642-687

2017

  1. Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia

    Journal of Hematology and Oncology, Vol. 10, Núm. 1

2008

  1. Energy restriction in obese subjects impact differently two mitochondrial function markers

    Journal of Physiology and Biochemistry, Vol. 64, Núm. 3, pp. 211-219